Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Netta Blondheim-Shraga, PhD, Senior Vice President of Research & Development at BrainStorm, will present new insights into ...

The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they can impair the cardiovascular system, so development often fails early on.

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...

Dental caries (tooth decay) is a common oral health condition that often causes significant pain and discomfort and may even ...

"We're proud to be a Semifinalist team of XPRIZE Healthspan, a 7-year, $101 million global competition that aims to ...

As, that fuels belly fat growth in middle age, offering a target for therapies to combat age-related obesity and disease.

Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies ...